MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology
Autor: | Olivier Tabary, Nathalie Rousselet, Philippe Le Rouzic, Florence Sonneville, Harriet Corvol, Sabine Blouquit-Laye, Manon Ruffin, Christelle Coraux |
---|---|
Přispěvatelé: | Centre de Recherche Saint-Antoine (UMRS893), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne Université (SU), Plasticité de l'épithélium respiratoire dans les conditions normales et pathologiques - UMR-S 903 (PERPMP), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-Institut National de la Santé et de la Recherche Médicale (INSERM)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Mucoviscidose: physiopathologie et phénogénomique [CRSA], Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service de Pneumologie pédiatrique [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), Tabary, Olivier |
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Science General Physics and Astronomy Cystic fibrosis General Biochemistry Genetics and Molecular Biology Article ANO1 03 medical and health sciences 0302 clinical medicine Downregulation and upregulation Medicine lcsh:Science [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology Multidisciplinary biology business.industry Calcium channel General Chemistry Anatomy respiratory system medicine.disease Mucus Cystic fibrosis transmembrane conductance regulator 3. Good health 030104 developmental biology 030220 oncology & carcinogenesis Chloride channel Cancer research biology.protein lcsh:Q business Anoctamin-1 [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology |
Zdroj: | Nature Communications Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.3231-3243. ⟨10.1038/s41467-017-00813-z⟩ Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017) Nature Communications, 2017, 8 (1), pp.3231-3243. ⟨10.1038/s41467-017-00813-z⟩ |
ISSN: | 2041-1723 |
DOI: | 10.1038/s41467-017-00813-z⟩ |
Popis: | Cystic fibrosis results from reduced cystic fibrosis transmembrane conductance regulator protein activity leading to defective epithelial ion transport. Ca2+-activated Cl− channels mediate physiological functions independently of cystic fibrosis transmembrane conductance regulator. Anoctamin 1 (ANO1/TMEM16A) was identified as the major Ca2+-activated Cl− channel in airway epithelial cells, and we recently demonstrated that downregulation of the anoctamin 1 channel in cystic fibrosis patients contributes to disease severity via an unknown mechanism. Here we show that microRNA-9 (miR-9) contributes to cystic fibrosis and downregulates anoctamin 1 by directly targeting its 3′UTR. We present a potential therapy based on blockage of miR-9 binding to the 3′UTR by using a microRNA target site blocker to increase anoctamin 1 activity and thus compensate for the cystic fibrosis transmembrane conductance regulator deficiency. The target site blocker is tested in in vitro and in mouse models of cystic fibrosis, and could be considered as an alternative strategy to treat cystic fibrosis. Downregulation of the anoctamin 1 calcium channel in airway epithelial cells contributes to pathology in cystic fibrosis. Here the authors show that microRNA-9 targets anoctamin 1 and that inhibiting this interaction improves mucus dynamics in mouse models. |
Databáze: | OpenAIRE |
Externí odkaz: |